- Home
- HTT vs NRC Comparison
HTT vs NRC Comparison
Compare HTT & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HTT
High Templar Tech Limited American depositary shares each representing one Class A ordinary share
Current Price
Company Overview
Basic Information| Metric | HTT | NRC |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | China | United States |
| Employees | 262 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 412.8M | 390.8M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | HTT | NRC |
|---|---|---|
| Price | $2.49 | $18.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 147.7K | 59.7K |
| Earning Date | 06-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.52% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.14 | ★ $0.36 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $1.88 | $10.26 |
| 52 Week High | $3.91 | $22.79 |
Technical Indicators
Market Signals| Indicator | HTT | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 49.62 | 60.56 |
| Support Level | $1.88 | $17.85 |
| Resistance Level | $2.69 | $18.18 |
| Average True Range (ATR) | 0.14 | 0.71 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 78.21 | 75.41 |
Price Performance
Historical ComparisonAbout HTT High Templar Tech Limited American depositary shares each representing one Class A ordinary share
High Templar Tech Ltd is an enabler of AI-driven technology. High Templar is focusing on exploring business opportunities globally to satisfy clients' demand by leveraging its technology know-how and financial service capabilities.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.